Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Osteoporosis International
Published in: Osteoporosis International 1/2018

01-01-2018 | Review

Complex interventions can increase osteoporosis investigations and treatment: a systematic review and meta-analysis

Authors: M. Kastner, L. Perrier, S. E. P. Munce, C. C. Adhihetty, A. Lau, J. Hamid, V. Treister, J. Chan, Y. Lai, S. E. Straus

Published in: Osteoporosis International | Issue 1/2018

Login to get access

Abstract

Osteoporosis is affecting over 200 million people worldwide. Despite available guidelines, care for these patients remains sub-optimal. We developed an osteoporosis tool to address the multiple dimensions of chronic disease management. Findings from its evaluation showed a significant increase from baseline in osteoporosis investigations and treatment, so we are revising this tool to include multiple chronic conditions including an update of evidence about osteoporosis. Our objectives were to conduct a systematic review of osteoporosis interventions in adults at risk for osteoporosis. We searched bibliometric databases for randomized controlled trials (RCTs) in any language evaluating osteoporosis disease management interventions in adults at risk for osteoporosis. Reviewer pairs independently screened citations and full-text articles, extracted data, and assessed risk of bias. Analysis included random effects meta-analysis. Primary outcomes were osteoporosis investigations and treatment, and fragility fractures. Fifty-five RCTs and one companion report were included in the analysis representing 165,703 patients. Our findings from 55 RCTs and 18 sub-group meta-analyses showed that complex implementation interventions with multiple components consisting of at least education + feedback + follow-up significantly increased the initiation of osteoporosis medications, and interventions with at least education + follow-up significantly increased the initiation of osteoporosis investigations. No significant impact was found for any type of intervention to reduce fracture. Complex interventions that include at least education + follow-up or feedback have the most potential for increasing osteoporosis investigations and treatment. Patient education appears to be an important component in osteoporosis disease management.
Appendix
Available only for authorised users
Literature
1.
Gullberg B, Johnell O, Kanis JA (1997) World-wide projections for hip fracture. Osteoporos Int 7:407–413CrossRefPubMed
2.
Cooper C, Campion G, Melton LJ 3rd (1992) Hip fractures in the elderly: a world-wide projection. Osteoporos Int 2(6):285–289CrossRefPubMed
3.
Kanis JA (2007) WHO Technical Report. University of Sheffield, UK, p 66
4.
5.
Burge R, Dawson-Hughes B, Solomon DH, Wong JB, King A, Tosteson A (2007) Incidence and economic burden of osteoporosis-related fractures in the United States, 2005-2025. J Bone Min Res 22(3):465–475CrossRef
6.
7.
Goeree R, Blackhouse G, Adachi J (2006) Cost-effectiveness of alternative treatments for women with osteoporosis in Canada. Curr Med Res Opin 22(7):1425–1436CrossRefPubMed
8.
Pike C, Brnbaum HG, Schiller M, Sharma H, Burge R, Edgell ET (2010) Direct and indirect costs of non-vertebral fracture patients with osteoporosis in the US. PharmacoEconomics 28(5):395–409CrossRefPubMed
9.
NIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis, and Therapy (2001) Osteoporosis prevention, diagnosis and therapy. JAMA 285(6):785–795
10.
11.
Wiktorowicz ME, Goeree R, Papaioannou A, Adachi JD, Papadimitropoulos E (2001) Economic implications of hip fracture: health service use, institutional care and cost in Canada. Osteoporos Int 12(4):271–278CrossRefPubMed
12.
Hopkins RB, Burke N, Von Keyserlingk C, Leslie WD, Morin SN, Adachi JD, Papaioannou A, Bessette L, Brown JP, Pericleous L, Tarride J (2016) The current economic burden of illness of osteoporosis in Canada. Osteoporos Int 27(10):3023–3032
13.
14.
Ioannidis G, Papaioannou A, Hopman W et al (2009) Relation between fractures and mortality: results from the Canadian Multicentre Osteoporosis Study. CMAJ 181(5):265–271CrossRefPubMedPubMedCentral
15.
Lips P, van Schoor NM (2005) Quality of life in patients with osteoporosis. Osteoporos Int 16:447–455CrossRefPubMed
16.
Cummings SR, Melton LJ (2002) Epidemiology and outcomes of osteoporotic fractures. Lancet 359:1761–1767CrossRefPubMed
17.
Adachi JD, Ioannidis G, Pickard L et al (2003) The association between osteoporotic fractures and health-related quality of life as measured by the Health Utilities Index in the Canadian Multicentre Osteoporosis Study (CaMos). Osteoporos Int 14:895–904CrossRefPubMed
18.
Papaioannou A, Morin S, Cheung A et al (2010) 2010 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada: summary. CMAJ 182(17):1864–1873CrossRefPubMedPubMedCentral
19.
20.
Committee on Practice Bulletins-Gynecology, The American College of Obstetricians and Gynecologists (2012) ACOG Committee on Practice Bulletins N. 129. Osteoporosis. Obstet Gynecol 120(3):718–734
21.
Silverman SL, Cummings SR, Watts NB (2008) Recommendations for the clinical evaluation of agents for treatment of osteoporosis: consensus of an expert panel representing the American Society for Bone and Mineral Research (ASMBR), the International Society for Clinical Densitometry (ISDR), and the National Osteoporosis Foundation (NOF). J Bone Miner Res 23(1):159–165CrossRefPubMed
22.
Bessette L, Ste-Marie LG, Jean S et al (2008) The care gap in diagnosis and treatment of women with a fragility fracture. Osteoporos Int 19:79–86CrossRefPubMed
23.
Jaglal SB, McIsaac WJ, Hawker G, Carroll J, Jaakkimainen L et al (2003) Information needs in the management of osteoporosis in family practice: an illustration of the failure of the current guideline implementation process. Osteoporos Int 14:672–676CrossRefPubMed
24.
Cheng N, Green ME (2008) Osteoporosis screening for men: are family physicians following guidelines? Can Fam Phys 54:1140–1141 e1-5
25.
Papaioannou A, Giangregorio L, Kvern B, Boulos P, Ioannidis G, Adachi JD (2004) The osteoporosis care gap in Canada. BMC Musculoskelet Disord 6:5–11
26.
Papaioannou A, Kennedy CC, Ioannidis G et al (2008) The osteoporosis care gap in men with fragility fractures: the Canadian Multicentre Osteoporosis Study. Osteoporos Int 19:581–587CrossRefPubMed
27.
Grimshaw JM, Thomas RE, MacLennan G et al (2004) Effectiveness and efficiency of guideline dissemination and implementation strategies. Health Technol Assess 8(6):iii–iiv 1–72CrossRefPubMed
28.
Graham I, Logan J, Harrison M et al (2006) Lost in knowledge translation: time for a map? J Contin Educ Heal Prof 26:13–24CrossRef
29.
Craig P, Dieppe P, Macintyre S, Michie S, Nazareth I, Petticrew M et al (2008) Developing and evaluating complex interventions: the new Medical Research Council guidance. BMJ a1655:337
30.
Kastner M, Straus SE (2012) Application of the Knowledge-to-Action and Medical Research Council frameworks in the development of an osteoporosis clinical decision support tool. J Clin Epidemiol 65:1163–1170CrossRefPubMed
31.
Kastner M, Straus SE (2008) Clinical decision support tools for osteoporosis disease management: a systematic review of randomized controlled trials. JGIM 23(12):2095–2105CrossRefPubMedPubMedCentral
32.
Kastner M, Li J, Lottridge D, Marquez C, Newton D, Straus SE (2010) Development of a prototype clinical decision support tool for osteoporosis disease management: a qualitative study of focus groups. BMC Med Inform Dec Mak 10:40CrossRef
33.
Kastner M, Lottridge D, Marquez C, Newton D, Straus SE (2010) Usability evaluation of a clinical decision support tool for osteoporosis disease management. Implement Sci 5:96CrossRefPubMedPubMedCentral
34.
Kastner M, Sawka AM, Hamid J, Chen M, Thorpe K, Chignell M, Ewusie J, Marquez C, Newton D, Straus SE (2014) A knowledge translation tool improved osteoporosis disease management in primary care: an interrupted time series analysis. Implement Sci 9:109CrossRefPubMedPubMedCentral
35.
Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ 339:b2535CrossRefPubMedPubMedCentral
36.
Haynes RB, McKibbon KA, Wilczynski NL, Walter SD, Werre SR, Hedges Team (2005) Optimal search strategies for retrieving scientifically strong studies of treatment from MEDLINE: analytical survey. BMJ 330(7501):1179CrossRefPubMedPubMedCentral
37.
Stone PW (2002) Popping the (PICO) question in research and evidence-based practice. Appl Nurs Res 15(3):197–198CrossRefPubMed
38.
39.
Higgins J, Moher D, Altman D, Gotzsche P, Juni P et al (2011) The Cochrane Collaboration’s tool for assessing risk of bias in randomized trials. BMJ d5928:343
40.
Balshem H, Helfand M, Schünemann HJ et al (2011) GRADE guidelines: 3. Rating the quality of evidence. J Clin Epidemiol 64(4):401–406CrossRefPubMed
41.
Higgins JPT, Thompson SG (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21:1539–1558CrossRefPubMed
42.
Barr R, Stewart A, Torgerson D et al (2005) Screening elderly women for risk of future fractures—participation rates and impact on incidence of falls and fractures. Calcif Tissue Int 76:243–248CrossRefPubMed
43.
Beattie K, Ioannidis G, MacDermid J et al (2014) Appropriate osteoporosis treatment by family physicians in response to FRAX vs CAROC reporting: results from a randomized controlled trial. J Clin Densitom 17:458–465CrossRefPubMed
44.
Bessette L, Davison K, Jean S et al (2011) The impact of two educational interventions on osteoporosis diagnosis and treatment after fragility fracture: a population-based randomized controlled trial. Osteoporos Int 22:2963–2972CrossRefPubMed
45.
Bliuc D, Eisman J, Center JA (2006) randomized study of two different information-based interventions on the management of osteoporosis in minimal and moderate trauma fractures. Osteoporos Int 17:1309–1317CrossRefPubMed
46.
Boyd J, Holcomb J, Rothenberg R (2002) Physician treatment of osteoporosis in response to heel ultrasound bone mineral density reports. J Clin Densitom 5:375–381CrossRefPubMed
47.
Ciaschini P, Straus S, Dolovich L et al (2010) Community based intervention to optimize osteoporosis management: randomized controlled trial. BMC Geriatr 10:60CrossRefPubMedPubMedCentral
48.
Clark E, Gould V, Morrison L et al (2012) Randomized controlled trial of a primary care-based screening program to identify older women with prevalent osteoporotic vertebral fractures: Cohort for Skeletal Health in Bristol and Avon (COSHIBA). J Bone Miner Res 27:664–671CrossRefPubMed
49.
50.
Cox H, Puffer S, Morton V et al (2008) Educating nursing home staff on fracture prevention: a cluster randomised trial. Age Ageing 37:167–172CrossRefPubMed
51.
Cram P, Schlechte J, Christensen A (2006) A randomized trial to assess the impact of direct reporting of DXA scan results to patients on quality of osteoporosis care. J Clin Densitom 9:393–398CrossRefPubMed
52.
Cranney A, Lam M, Ruhland L et al (2008) A multifaceted intervention to improve treatment of osteoporosis in postmenopausal women with wrist fractures: a cluster randomized trial. Osteoporos Int 19:1733–1740CrossRefPubMed
53.
Curtis J, Westfall A, Allison J et al Challenges in improving the quality of osteoporosis care for long-term glucocorticoid users: a prospective randomized trial. Arch Intern Med 167:591–596
54.
Davis J, Guy P, Ashe M et al HipWatch: osteoporosis investigation and treatment after a hip fracture: a 6-month randomized controlled trial. J Gerontol A Biol Sci Med Sci 62:888–891
55.
Devereux K, Robertson D, Briffa N (2005) Effects of a water-based program on women 65 years and over: a randomized controlled trial. Aust J Physiother 51:102–108CrossRefPubMed
56.
Feldstein A, Elmer P, Smith D et al (2006) Electronic medical record reminder improves osteoporosis management after a fracture: a randomized, controlled trail. J Am Geriatr Soc 54:450–457CrossRefPubMed
57.
Gardner M, Brophy R, Demetrakopoulos D et al (2005) Interventions to improve osteoporosis treatment following hip fracture. J Bone Joint Surg Am 87:3–7CrossRefPubMed
58.
Gianoudis J, Bailey C, Ebeling P et al (2014) Effects of a targeted multimodal exercise program incorporating high-speed power training on falls and fracture risk factors in older adults: a community-based randomized controlled trial. J Bone Miner Res 29:182–191CrossRefPubMed
59.
Heyworth L, Kleinman K, Oddleifson S et al (2014) Comparison of interactive voice response, patient mailing, and mailed registry to encourage screening for osteoporosis: a randomized controlled trial. Osteoporos Int 25:1519–1526CrossRefPubMed
60.
Jaglal S, Donescu O, Bansod V et al (2012) Impact of a centralized osteoporosis coordinator on post-fracture osteoporosis management: a cluster randomized trial. Osteoporosis Int 23:87–95CrossRef
61.
Kessous R, Weintraub A, Mattan Y et al (2014) Improving compliance to osteoporosis workup and treatment in postmenopausal patients after a distal radius fracture. Taiwan J Obstet Gynecol 53:206–209CrossRefPubMed
62.
Kilgore M, Outman R, Locher J et al (2013) Multimodal intervention to improve osteoporosis care in home health settings: results from a cluster randomized trial. Osteoporos Int 24:2555–2560CrossRefPubMedPubMedCentral
63.
Klop C, de Vries F, Vinks T et al (2014) Increase in prophylaxis of glucocorticoid-induced osteoporosis by pharmacist feedback: a randomised controlled trial. Osteoporos Int 25:385–392CrossRefPubMed
64.
LaCroix A, Buist D, Brenneman S et al (2005) Evaluation of three population-based strategies for fracture prevention: results of the osteoporosis population-based risk assessment (OPRA) trial. Med Care 43:293–302CrossRefPubMed
65.
66.
Lai P, Chua S, Chew Y et al (2011) Effects of pharmaceutical care on adherence and persistence to bisphosphonates in postmenopausal osteoporotic women. J Clin Pharm Ther 36:557–567CrossRefPubMed
67.
Leslie W, LaBine L, Klassen P et al (2012) Closing the gap in postfracture care at the population level: a randomized controlled trial. CMAJ 184:290–296CrossRefPubMedPubMedCentral
68.
Lesnyak O, Ludmila P, Natalia K et al (2012) Multicenter randomized trial of interactive educational program in patients with osteoporosis [abstract]. Osteoporos Int 23(Suppl 2):P232
69.
Levy B, Hartz A, Woodworth G et al (2009) Interventions to improving osteoporosis screening: an Iowa Research Network (IRENE) study. J Am Board Fam Med 22:360–367CrossRefPubMed
70.
Lin H, Chen X, Zhu X et al (2012) The effects of health management intervention on postmenopausal osteoporosis women treatment [abstract]. Osteoporos Int 23(Suppl 2):P149
71.
Majumdar S, Beaupre L, Harley C et al (2007) Use of a case manager to improve osteoporosis treatment after hip fracture: results of a randomized controlled trial. Arch Intern Med 167:2110–2115CrossRefPubMed
72.
Majumdar S, Johnson J, McAlister F et al (2008) Multifaceted intervention to improve diagnosis and treatment of osteoporosis in patients with recent wrist fracture: a randomized controlled trial. CMAJ 178:569–575CrossRefPubMedPubMedCentral
73.
Majumdar S, Johnson J, Bellerose D et al (2011) Nurse case-manager vs multifaceted intervention to improve quality of osteoporosis care after wrist fracture: randomized controlled pilot study. Osteoporos Int 22:223–230CrossRefPubMed
74.
McConaha J, Berdine H, Skomo M et al (2014) Impact of the fracture risk assessment on patient and physician behavior in osteoporosis prevention. J Pharm Pract 27:25–30CrossRefPubMed
75.
McDonough R, Doucette W, Kumbera P et al (2005) An evaluation of managing and educating patients on the risk of glucocorticoid-induced osteoporosis. Value Health 8:24–31CrossRefPubMed
76.
McLeod K, Johnson S, Rasali D et al (2012) Impact of a theory-based osteoporosis education intervention on calcium and vitamin D supplement intake in older adults: a randomized controlled trial [abstract]. Osteoporos Int 23(Suppl 2):P233
77.
Morrison L, Tobias J (2005) Effect of a case-finding strategy for osteoporosis on bisphosphonate prescribing in primary care. Osteoporos Int 16:71–77CrossRefPubMed
78.
Oh E, Yoo J, Lee J et al (2014) Effects of a three-month therapeutic lifestyle modification program to improve bone health in postmenopausal Korean women in a rural community: a randomized controlled trial. Res Nurs Health 37:292–301CrossRefPubMed
79.
Olegario R, Kjell J Teng D et al (2012) Improving osteoporosis outreach effort: a randomized, controlled study of program effectiveness [abstract]. J Manag Care Pharm 18(2):P184
80.
Pekkaninen T, Löyttyniemi E, Välimäki M (2013) Hip fracture prevention with a multifactorial educational program in elderly community-dwelling Finnish women. Osteoporos Int 24:2983–2992CrossRef
81.
Plawecki K, Chapman-Novakofski K (2013) Effectiveness of community intervention in improving bone health behaviors in older adults. J Nutr Gerontol Geriatr 32:145–160CrossRefPubMed
82.
Qi B, Resnick B, Smeltzer S et al (2011) Self-efficacy program to prevent osteoporosis among Chinese immigrants: a randomized controlled trial. Nurs Res 60:393–404CrossRefPubMed
83.
Queally J, Kiernan C, Shaikh M et al (2013) Initiation of osteoporosis assessment in the fracture clinic results in improved osteoporosis management: a randomised controlled trial. Osteoporos Int 24:1089–1094CrossRefPubMed
84.
Rolnick S, Kopher R, Jackson J et al (2001) What is the impact of osteoporosis education and bone mineral density testing for postmenopausal women in a managed care setting? Menopause 8:141–148CrossRefPubMed
85.
Roux S, Beaulieu M, Beaulieu MC et al (2013) Priming primary care physicians to treat osteoporosis after a fragility fracture: an integrated multidisciplinary approach. J Rheumatol 40:703–711CrossRefPubMed
86.
Rozental T, Makhni E, Day C et al (2008) Improving evaluation and treatment for osteoporosis following distal radial fractures. A prospective randomized intervention. J Bone Joint Surg Am 90:953–961CrossRefPubMed
87.
Sjöberg C, Wallerstedt S (2013) Effects of medication reviews performed by a physician on treatment with fracture-preventing and fall-risk-increasing drugs in older adults with hip fracture—a randomized controlled study. J Am Geriatr Soc 61:1464–1472CrossRefPubMed
88.
Solomon D, Katz J, La Tourette A et al (2004) Multifaceted intervention to improve rheumatologists’ management of glucocorticoid-induced osteoporosis: a randomized controlled trial. Arthritis Rheum 51:383–387CrossRefPubMed
89.
Solomon D, Finkelstein J, Polinski J et al (2006) A randomized controlled trial of mailed osteoporosis education to older adults. Osteoporos Int 17:760–767CrossRefPubMed
90.
Solomon D, Polinski J, Stedman M et al (2007) Improving care of patients at-risk for osteoporosis: a randomized controlled trial. J Gen Intern Med 22:362–367CrossRefPubMedPubMedCentral
91.
Solomon D, Katz J, Finkelstein J et al (2007) Osteoporosis improvement: a large-scale randomized controlled trial of patient and primary care physician education. J Bone Miner Res 22:1808–1815CrossRefPubMed
92.
Solomon D, Iversen M, Avorn J et al (2012) Osteoporosis telephonic intervention to improve medication regimen adherence: a large, pragmatic, randomized controlled trial. Arch Intern Med 172:477–483CrossRefPubMedPubMedCentral
93.
Tüzün S, Akyüz G, Eskiyurt N et al (2013) Impact of the training on the compliance and persistence of weekly bisphosphonate treatment in postmenopausal osteoporosis: a randomized controlled study. Int J Med Sci 10:1880–1887CrossRefPubMedPubMedCentral
94.
Warriner A, Outman R, Kitchin E et al (2012) A randomized trial of a mailed intervention and self-scheduling to improve osteoporosis screening in postmenopausal women. J Bone Miner Res 27:2603–2610CrossRefPubMedPubMedCentral
95.
Warriner A, Outman R, Feldstein A et al (2014) Effect of self-referral on bone mineral density testing and osteoporosis treatment. Med Care 52:743–750CrossRefPubMedPubMedCentral
96.
Yuksel N, Majumdar S, Biggs C et al (2010) Community pharmacist-initiated screening program for osteoporosis: randomized controlled trial. Osteoporos Int 21:391–398CrossRefPubMed
97.
Crandall CJ (2015) Risk assessment tools for osteoporosis screening in postmenopausal women: a systematic review. Curr Osteoporos Rep 13(5):287–301CrossRefPubMed
98.
Marques A, Ferreira RJ, Santos E, Loza E, Carmona L, da Silva JA (2015) The accuracy of osteoporotic fracture risk prediction tools: a systematic review and meta-analysis. Ann Rheum Dis 74(11):1958–1967CrossRefPubMed
99.
Kanis JA, Harvey NC, Cooper C, Johansson H, Oden A, McCloskey EV (2016) Advisory Board of the National Osteoporosis Guideline Group. A systematic review of intervention thresholds based on FRAX: a report prepared for the National Osteoporosis Guideline Group and the International Osteoporosis Foundation. Arch Osteoporos 11(1):25CrossRefPubMedPubMedCentral
100.
Hoiberg MP, Rubin KH, Hermann AP, Brixen K, Abrahamsen B (2016) Diagnostic devices for osteoporosis in the general population: a systematic review. Bone 92:58–69CrossRefPubMed
101.
Nayak S, Edwards DL, Saleh AA, Greenshpan SL (2015) Systematic review and meta-analysis of the performance of clinical risk assessment instruments for screening for osteoporosis or low bone density. Osteoporos Int 26(5):1543–1554CrossRefPubMedPubMedCentral
102.
Halldorsson BV, Bjornsson AH, Gudmundsson HT, Birgisson EO, Ludviksson BR, Gudbjornsson B (2015) A clinical decision support system for the diagnosis, fracture risks and treatment of osteoporosis. Comput Math Methods Med 2015. https://​doi.​org/​10.​1155/​2015/​189769
103.
Canadian Agency for Drugs and Technologies in Health (2015) CADTH Common Drug Reviews. Denosumab (Prolia): treatment to increase bone mass in men with osteoporosis at high risk for fracture; or who have failed or are intolerant to other available osteoprosis therapy [Internet]
104.
Molvik H, Khan W (2015) Bisphosphonates and their influence on fracture healing: a systematic review. Osetoporos Int 26(4):1251–1260CrossRef
105.
Gauthier K, Bai A, Perras C, Cunningham J, Ahuja T, Richter T, Kovacs C (2012) Denosumab, raloxifene, and zoledronic acid for the treatment of postmenopausal osteoporosis: clinical effectiveness and harms [Internet]. CADTH Rapid Response Reports. Canadian Agency for Drugs and Technologies in Health, Ottawa
106.
Feng Z, Zeng S, Wang Y, Zheng Z, Chen Z (2013) Bisphosphonates for the prevention and treatment of osteoporosis in patients with rheumatic diseases: a systematic review and meta-analysis. PLoS One 8(12):e80890CrossRefPubMedPubMedCentral
107.
Eriksen EF, Diez-Perez, Boonen S (2014) Update on long-term treatment with bisphosphonates for postmenopausal osteoporosis: a systematic review. Bone 58:126–135CrossRefPubMed
108.
Schupfner R, Stoevelaar HJ, Blattert T, Fagan D, Marcia S, Schils F, Siddiqi MA, Anselmetti GC (2016) Treatment of osteoportic vertebral compression fractures: applicability of appropriateness criteria in clinical practice. Pain Physician 19(1):E113–E120PubMed
109.
MacLean C, Newberry S, Maglione M, McMahon M, Ranganath V, Suttorp M et al (2008) Systematic review: comparative effectiveness of treatments to prevent fractures in men and women with low bone density or osteoporosis. Ann Intern Med 148(3):197–213CrossRefPubMed
110.
Crandall CJ, Newberry SJ, Diamant A, Lim YW, Gellad WF, Booth MJ, Motala A, Shekelle PG (2015) Comparative effectiveness of pharmacologic treatments to prevent fractures: an updated systematic review. Ann Int Med 161(10):711–723CrossRef
111.
Al-Sari UA, Tobias J, Clark E (2016) Health-related quality of life in older people with osteoporotic vertebral fractures: a systematic review and meta-analysis. Osteoporos Int 27(10):2891–2900
112.
Sampson M, McGowan J, Cogo E et al (2009) An evidence-based practice guideline for the peer review of electronic search strategies. J Clin Epidemiol 62:944–952CrossRefPubMed
Metadata
Title
Complex interventions can increase osteoporosis investigations and treatment: a systematic review and meta-analysis
Authors
M. Kastner
L. Perrier
S. E. P. Munce
C. C. Adhihetty
A. Lau
J. Hamid
V. Treister
J. Chan
Y. Lai
S. E. Straus
Publication date
01-01-2018
Publisher
Springer London
Published in
Osteoporosis International / Issue 1/2018
Print ISSN: 0937-941X
Electronic ISSN: 1433-2965
DOI
https://doi.org/10.1007/s00198-017-4248-0

Other articles of this Issue 1/2018

Osteoporosis International 1/2018 Go to the issue

Case Report

A novel dominant COL11A1 mutation in a child with Stickler syndrome type II is associated with recurrent fractures

Original Article

Prediction of major osteoporotic and hip fractures in Australian men using FRAX scores adjusted with trabecular bone score

Original Article

A meta-analysis of the association between body mass index and risk of vertebral fracture

Original Article

Effects of endogenous hypercortisolism on bone mRNA and microRNA expression in humans

Case Report

A novel COL1A2 C-propeptide cleavage site mutation causing high bone mass osteogenesis imperfecta with a regional distribution pattern

Journal News

Concise clinical reviews